Figure 1

Figure 2

Figure 3

Figure 4

Drugs/compounds encapsulated in niosomes and their antibacterial or antifungal effects
| Drug/compound(s) | Effects compared with unencapsulated form | Reference(s) |
|---|---|---|
| Itraconazole | Greater activity against Candida albicans | [100] |
| Diallyl disulfide | Greater activity against C. albicans | [101] |
| Fluconazole | Effective against corneal fungal infections | [102] |
| Miconazole | Effective against Trichophyton rubrum | [103] |
| Nisin and ethylenediaminetetraacetic acid | Better effect in inhibiting Staphylococcus aureus | [106] |
| Gallidermin | Better antibacterial effects against Propionibacterium acnes and S. aureus | [108] |
| Propolis | Enhanced antimicrobial effect | [110] |
| Gatifloxacin | Effective against ocular infections | [111] |
| Moxifloxacin | Used for topical microbial infections | [112] |
| Bismuth-ethanedithiol and tobramycin | Effective against Pseudomonas aeruginosa | [114] |
Drugs/compounds encapsulated in niosomes and their anticancer effects
| Drug/compound(s) | Effects | Reference(s) |
|---|---|---|
| Doxorubicin | Decreased proliferation of sarcoma cells | [26, 57] |
| Daunorubicin hydrochloride | Destroyed Dalton’s ascitic lymphoma cells | [52] |
| Bleomycin | Accumulated in higher levels at the tumor site | [52] |
| Methotrexate | Enhanced antitumor activity against sarcoma | [58] |
| 5-Fluorouracil | Enhanced drug penetration in the treatment of skin cancer | [59] |
| Vincristine | Enhanced antitumor activity against sarcoma | [5] |
| Tocotrienol | Enhanced cytotoxicity toward breast cancer cells | [61] |
| Curcumin | Enhanced cytotoxic and apoptotic effects toward ovarian cancer cells | [63] |
| Curcumin and doxorubicin hydrochloride | Enhanced cytotoxicity toward cervical cancer cells | [64] |
| Artemisinin | Cytotoxic toward melanoma cells | [68] |
| Tamoxifen citrate | Greater cytotoxicity against breast cancer cell line | [70] |
| Mitoxantrone | Greater cytotoxicity against human ovarian cancer and breast cancer cell lines | [71] |
| Cisplatin | Enhanced cytotoxicity toward breast cancer cells | [73] |